JPRN-UMIN000026791
Recruiting
未知
A prospective Randomized study comparing the effects of Empagliflozin versus Sitagliptin on Intra hepatic lipid content and hepatic insulin resistance in type 2 diabetes patients / Resistance study
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Omori Medical Center0 sites44 target enrollmentMarch 30, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Omori Medical Center
- Enrollment
- 44
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who meet all of the following criteria are included in this study.
- •1\. Type 2 diabetic patients with HbA1c below 10% at the time of consenting
- •2\. Female and male patients are 20 years old or older and younger than 75 years old
- •3\. Patients who can take liver biopsy for the purpose of evaluation or diagnosis of non\-alcohol fatty liver disease
- •4\. Patients with BMI 22 kg/m2 or higher
- •5\. Patients who can provide their written consent for participation of this study
Exclusion Criteria
- •Patients who fall into any of the following criteria are excluded from participating in the study.
- •1\. Patients with type 1 diabetes or secondary diabetes
- •2\. Patients with BMI lower than 22 kg/m2
- •3\. Patients with moderate to severe renal function disease or at the final stage of renal failure (eGFR lower than 45 mL/min/1\.73 m2\)
- •4\. Patients who had stroke or cerebral infarction within 12 weeks before giving their consent
- •5\. Patients with any medical history of myocardial infarction, angina pectoris, or currently with atrial fibrillation
- •6\. Patients with any infectious disease
- •7\. Patients with malignancy (However, those who have completed treatment and/or show no redevelopment of malignancy, as well as manifest some degree of remission can be considered to be participants of this study)
- •8\. Patients with connective tissue disease (However, those T2DM patients who have treated with prednisolone 5 mg or less and show stable conditions can be considered to be participants of this study)
- •9\. Patients with hepatocirrhosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A study was undertaken to see the spinal anaesthesia consequences in patients undergoing surgeries below navel region while using the local anaesthetics like levobupivacaine, bupivacaine and ropivacaine along with an additive nalbuphineHealth Condition 1: O- Medical and SurgicalCTRI/2023/04/051813PSG Institute of medical sciences and Research
Not yet recruiting
Not Applicable
To compare the effectiveness of two group of nerve blocks in patients undergoing upper arm and shoulder orthopaedic surgeries.Health Condition 1: O- Medical and SurgicalCTRI/2022/02/040120Dr Eva Sharma
Recruiting
Phase 1
A Prospective Randomized Study Comparing the Effectiveness of Intra-articular Ketorolac Injection and Steroid Injection in Adhesive CapsulitisPatients who have shoulder pain and diagnosed as having an adhesive capusiltis by the shoulder surgeons.Adhesive capsulitis,frozen shoulder,stiff shoulderTCTR20200501002/A84
Recruiting
Not Applicable
A proSpective randomized Study comparing the effects of Empagliflozin versus sitagliptin on cardiac fat and function in patients with Type 2 diabetes (ASSET study)JPRN-UMIN000026340the Japan Society for Patient Reported Outcome (PRO)44
Terminated
Not Applicable
A prospective randomized study of corticosteroid withdrawal in low-risk kidney transplant recipient selected by immune monitoring methodNot ApplicableKCT0000664Samsung Medical Center236